Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Perrigo (NY: PRGO )

37.42 +0.04 (+0.11%)
Official Closing Price Updated: 6:30 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,049,536
Open 37.52
Bid (Size) 36.53 (1)
Ask (Size) 38.09 (1)
Prev. Close 37.38
Today's Range 37.00 - 37.57
52wk Range 30.78 - 43.90
Shares Outstanding 133,714,781
Dividend Yield 2.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Perfect Presents to Gift Your 2023 Stock Portfolio
As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023. 
Via InvestorPlace
SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON
Stolkholm’s Best Kept Skincare Secret Is The Perfect Gift For Giving 
From ACO
Via Globe NewsWire

Performance

YTD
+6.28%
+6.28%
1 Month
+6.28%
+6.28%
3 Month
-7.10%
-7.10%
6 Month
-12.22%
-12.22%
1 Year
-1.71%
-1.71%

More News

Read More
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
FDA Postpones Review Meeting For First OTC Contraceptive Option From Perrigo
Via Benzinga
Perrigo Shares Pop On Raised FY22 Guidance Surpassing Consensus Estimates
Via Benzinga
Earnings Scheduled For May 11, 2022
Via Benzinga
Earnings Scheduled For March 1, 2022
Via Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Via Benzinga
Why Perrigo Stock Tanked on Tuesday
Via The Motley Fool
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
Via Benzinga
FDA Schedules AdComm Review For First Over The Counter Birth Control Pill
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
Via Benzinga
Is Sanofi A Buy, Despite Recent Stumbles?
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Earnings Scheduled For August 9, 2022
Via Benzinga
Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim
Via Investor's Business Daily
Perrigo Seeks FDA Approval For the First OTC Contraceptive Pill
Via Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
Via Benzinga
This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives
Via Benzinga
Bette Midler Panned For Breastfeeding Remark In Wake Of Baby Formula Shortage
Via Benzinga
Cannabis Movers & Shakers: MedMen's New CEO, TerrAscend, FoliuMed, Charlotte's Web & Proof Announce Appointments
Via Benzinga
Perrigo: Q4 Earnings Insights
Via Benzinga
Daily Report: Perrigo (PRGO)
Via Talk Markets
4 Stocks Insiders Are Buying
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.